Literature DB >> 23991374

Effects of aminoguanidine on retinal apoptosis in mice with oxygen-induced retinopathy.

An-Jie Du1, Bing Ren, Xiao-Wei Gao, Lei Yang, Yan Fu, Xu-Dong Zhao.   

Abstract

AIM: To explore the protective effects of aminoguanidine (AG) on retinal apoptosis in mice with oxygen-induced retinopathy (OIR).
METHODS: A total of 80 C57BL/6J mice, aged 7 days, were randomly divided into four groups: normal, high oxygen, high oxygen saline and high oxygen treated with AG. In the normal group, mice were housed in normoxic conditions from postnatal day P7 to P17. Mice in the other 3 groups were placed under hyperoxic conditions (75±2%O2) in an oxygen-regulated chamber for 5 days and subsequently placed in normoxic conditions for 5 days. Mice in the AG group were treated once daily, from P12 to P17, with AG hemisulfate (100mg/kg body weight, intraperitoneally) dissolved in physiological saline. An equivalent amount of 0.9% physiological saline was administered, as above, to mice in the high oxygen saline group. Ten mice were randomly selected from each group on P14 and on P17, euthanized and the retinas examined. Apoptotic cells in the retina were detected using the terminal-deoxynucleoitidyl transferase mediated nick end labeling (TUNEL) method. The expression of nitric oxide synthase (iNOS) in the retina was detected by immunohistochemistry and changes in rod cells were observed using electron microscopy.
RESULTS: TUNEL-positive cells and iNOS immunoreactive neurons were present in the inner nuclear and ganglion cell retinal layers of mice in the high oxygen group. The number of TUNEL-positive cells was significantly greater in the high oxygen group compared with the normal group (t=-20.81, P 14d <0.05; t=-15.05, P 17d <0.05). However, the number of TUNEL-positive cells in the AG treatment group was significantly lower (t=-13.21, P 14d<0.05; t=-6.61, P 17d <0.05) compared with the high oxygen group. The expression of iNOS was significantly higher in the high oxygen group compared with the normal group (t=-21.95, P 14d<0.05; t=-17.30, P 17d<0.05). However, the expression of iNOS in the AG treatment group was significantly lower (t=-12.17, P 14d<0.05; t=-10.30, P 17d<0.05) compared with the high oxygen group. The outer segments of the rods were disorganized and short in the high oxygen group. Rod morphology appeared to be slightly improved in the AG group.
CONCLUSION: AG may protect retinal neurons in OIR by inhibiting apoptosis. The mechanism may be related to iNOS.

Entities:  

Keywords:  aminoguanidine; apoptosis; inhibitor of nitric oxide synthase; retinopathy of prematurity

Year:  2013        PMID: 23991374      PMCID: PMC3755299          DOI: 10.3980/j.issn.2222-3959.2013.04.05

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  24 in total

1.  Development of scotopic visual thresholds in retinopathy of prematurity.

Authors:  Amber M Barnaby; Ronald M Hansen; Anne Moskowitz; Anne B Fulton
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

2.  Angiotensin type-1 receptor inhibition is neuroprotective to amacrine cells in a rat model of retinopathy of prematurity.

Authors:  Laura E Downie; Kate M Hatzopoulos; Michael J Pianta; Algis J Vingrys; Jennifer L Wilkinson-Berka; Michael Kalloniatis; Erica L Fletcher
Journal:  J Comp Neurol       Date:  2010-01-01       Impact factor: 3.215

3.  [Epidemiology of retinopathy of prematurity in public services from Argentina during 2008].

Authors:  Celia C Lomuto; Lidia Galina; Marina Brussa; Ana Quiroga; Ernesto Alda; Alicia M Benítez; Liliana Bouzas; N Alejandro Dinerstein; Norma Erpen; Jorgelina Falbo; Julio Manzitti; Silvia Marinaro; Ricardo Nieto; Teresa Sepúlveda; Patricia Visintín
Journal:  Arch Argent Pediatr       Date:  2010-02       Impact factor: 0.635

4.  Inducible nitric oxide synthase inhibitors abolished histological protection by late ischemic preconditioning in rat retina.

Authors:  Kenji Sakamoto; Yuzuru Yonoki; Yuko Kubota; Mayumi Kuwagata; Maki Saito; Tsutomu Nakahara; Kunio Ishii
Journal:  Exp Eye Res       Date:  2005-09-29       Impact factor: 3.467

5.  Loss of retinal ganglion cells following retinal ischemia: the role of inducible nitric oxide synthase.

Authors:  Arthur H Neufeld; Shin ichiro Kawai; Sucharita Das; Smita Vora; Elizabeth Gachie; Jane R Connor; Pamela T Manning
Journal:  Exp Eye Res       Date:  2002-11       Impact factor: 3.467

6.  Inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy.

Authors:  Florian Sennlaub; Yves Courtois; Olivier Goureau
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

7.  Interaction between iNOS and COX-2 in hypoxia-induced retinal neovascularization in mice.

Authors:  Tao He; Yi-Qiao Xing; Xiao-Hui Zhao; Ming Ai
Journal:  Arch Med Res       Date:  2007-08-20       Impact factor: 2.235

8.  Oxygen-induced retinopathy in the mouse.

Authors:  L E Smith; E Wesolowski; A McLellan; S K Kostyk; R D'Amato; R Sullivan; P A D'Amore
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-01       Impact factor: 4.799

9.  Suppression of retinal neovascularization by the iNOS inhibitor aminoguanidine in mice of oxygen-induced retinopathy.

Authors:  Qiong Zhang; Jingfa Zhang; Yuan Guan; Shisheng Zhang; Caihong Zhu; Guo-Tong Xu; Ling Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-03-20       Impact factor: 3.117

10.  Arginase 2 deletion reduces neuro-glial injury and improves retinal function in a model of retinopathy of prematurity.

Authors:  Subhadra P Narayanan; Jutamas Suwanpradid; Alan Saul; Zhimin Xu; Amber Still; Robert W Caldwell; Ruth B Caldwell
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

View more
  2 in total

1.  Aminoguanidine reduces diabetes-associated cardiac fibrosis.

Authors:  Fernando Magdaleno; Chuck Christopher Blajszczak; Claudia Lisette Charles-Niño; Alma Marlene Guadrón-Llanos; Alan Omar Vázquez-Álvarez; Alejandra Guillermina Miranda-Díaz; Natalia Nieto; María Cristina Islas-Carbajal; Ana Rosa Rincón-Sánchez
Journal:  Exp Ther Med       Date:  2019-08-20       Impact factor: 2.447

2.  Candesartan stimulates reparative angiogenesis in ischemic retinopathy model: role of hemeoxygenase-1 (HO-1).

Authors:  Ahmed Y Shanab; Sally L Elshaer; Mona F El-Azab; Sahar Soliman; Harika Sabbineni; Suraporn Matragoon; Susan C Fagan; Azza B El-Remessy
Journal:  Angiogenesis       Date:  2014-11-25       Impact factor: 9.596

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.